(DLB) Dolby Laboratories - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US25659T1079

Audio Codecs, Video Codecs, Cinema Systems, Immersive Media

Stock: Electronic Components
Age 20.9y

MCap 6,051m
Avg Vol 527K (34.7M USD)

Beta 0.804
Volatility 22.98%

EPS (Earnings per Share)

EPS CAGR: -48.03%
EPS Trend: -18.7%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: -3.55%
Rev. Trend: 6.1%

Last SUE: 0.01
Qual. Beats: 0

Dividends

Dividend Yield	1.83%
Yield on Cost 5y	1.54%
Yield CAGR 5y	10.36%
Payout Consistency	87.0%
Payout Ratio	34.2%

Risk via 5d forecast
Volatility	23.0%
Value at Risk 5%th	33.0%
Relative Tail Risk	-12.74%

Reward TTM
Sharpe Ratio	-1.06
Alpha	-37.10
CAGR/Max DD	-0.22

Character TTM
Hurst Exponent	0.352
Beta	0.804
Beta Downside	0.757

Drawdowns 3y
Max DD	28.18%
Mean DD	11.27%
Median DD	10.87%

Description: DLB Dolby Laboratories January 07, 2026

Dolby Laboratories (NYSE:DLB) designs and manufactures audio, imaging, and accessibility hardware and software for TV, broadcast, and live-entertainment markets worldwide, licensing its core codecs (AAC, HE-AAC, Dolby Atmos, Dolby Vision, DD+, AC-4, HEVC) to device makers, content creators, and service providers.

The firm’s product portfolio spans premium cinema solutions (Dolby Cinemas), a cloud-based developer platform (Dolby.io) for real-time immersive experiences, and a suite of digital cinema servers, processors, amplifiers, and loudspeakers that support theatrical, broadcast, and home-entertainment distribution.

Recent KPI highlights: FY 2024 revenue grew ~9% YoY to $1.78 billion, with the SaaS segment (Dolby.io) posting a 35% compound annual growth rate over the past three years, and operating margin expanding to 21% as licensing revenue benefits from the global shift toward streaming and immersive content. Key sector drivers include rising consumer demand for high-dynamic-range video and object-based audio in OTT platforms, and the continued rollout of 5G, which accelerates adoption of low-latency, cloud-native media workflows.

For a deeper quantitative look at Dolby’s valuation dynamics, you might explore the analytics on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (255.0m TTM) > 0 and > 6% of Revenue (6% = 80.9m TTM)

FCFTA 0.13 (>2.0%) and ΔFCFTA 3.84pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 70.45% (prev 60.97%; Δ 9.48pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.15 (>3.0%) and CFO 472.2m > Net Income 255.0m (YES >=105%, WARN >=100%)

Net Debt (-663.0m) to EBITDA (387.8m) ratio: -1.71 <= 3.0 (WARN <= 3.5)

Current Ratio 3.17 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (96.8m) change vs 12m ago 0.26% (target <= -2.0% for YES)

Gross Margin 88.13% (prev 88.97%; Δ -0.84pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 42.44% (prev 40.69%; Δ 1.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -20.24 (EBITDA TTM 387.8m / Interest Expense TTM -14.3m) >= 6 (WARN >= 3)

Altman Z'' 9.83

(A) 0.29 = (Total Current Assets 1.39b - Total Current Liabilities 437.8m) / Total Assets 3.23b

(B) 0.82 = Retained Earnings (Balance) 2.63b / Total Assets 3.23b

warn (B) unusual magnitude: 0.82 — check mapping/units

(D) 4.40 = Book Value of Equity 2.62b / Total Liabilities 595.8m

Total Rating: 9.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 67.66

1. Piotroski 5.0pt

2. FCF Yield 7.99%

3. FCF Margin 31.89%

4. Debt/Equity 0.01

5. Debt/Ebitda -1.71

6. ROIC - WACC (= 0.66)%

7. RoE 9.90%

8. Rev. Trend 6.08%

9. EPS Trend -18.73%

What is the price of DLB shares?

As of January 20, 2026, the stock is trading at USD 62.48 with a total of 566,827 shares traded.
Over the past week, the price has changed by -3.01%, over one month by -5.69%, over three months by -8.68% and over the past year by -21.91%.

Is DLB a buy, sell or hold?

Dolby Laboratories has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy DLB.

Strong Buy: 2
Buy: 2
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the DLB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	90.5	44.8%
Analysts Target Price	90.5	44.8%
ValueRay Target Price	60	-3.9%

DLB Fundamental Data Overview January 17, 2026

P/E Trailing = 24.1832
P/E Forward = 15.083
P/S = 4.4853
P/B = 2.3077
P/EG = 2.0755
Revenue TTM = 1.35b USD
EBIT TTM = 289.2m USD
EBITDA TTM = 387.8m USD
Long Term Debt = 38.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 10.4m USD (from shortTermDebt, last quarter)
Debt = 38.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -663.0m USD (from netDebt column, last quarter)
Enterprise Value = 5.39b USD (6.05b + Debt 38.9m - CCE 701.9m)
Interest Coverage Ratio = -20.24 (Ebit TTM 289.2m / Interest Expense TTM -14.3m)
EV/FCF = 12.52x (Enterprise Value 5.39b / FCF TTM 430.3m)
FCF Yield = 7.99% (FCF TTM 430.3m / Enterprise Value 5.39b)
FCF Margin = 31.89% (FCF TTM 430.3m / Revenue TTM 1.35b)
Net Margin = 18.90% (Net Income TTM 255.0m / Revenue TTM 1.35b)
Gross Margin = 88.13% ((Revenue TTM 1.35b - Cost of Revenue TTM 160.1m) / Revenue TTM)
Gross Margin QoQ = 87.13% (prev 86.06%)
Tobins Q-Ratio = 1.67 (Enterprise Value 5.39b / Total Assets 3.23b)
Interest Expense / Debt = 0.29% (Interest Expense 114.0k / Debt 38.9m)
Taxrate = 15.48% (47.0m / 303.5m)
NOPAT = 244.4m (EBIT 289.2m * (1 - 15.48%))
Current Ratio = 3.17 (Total Current Assets 1.39b / Total Current Liabilities 437.8m)
Debt / Equity = 0.01 (Debt 38.9m / totalStockholderEquity, last quarter 2.62b)
Debt / EBITDA = -1.71 (Net Debt -663.0m / EBITDA 387.8m)
Debt / FCF = -1.54 (Net Debt -663.0m / FCF TTM 430.3m)
Total Stockholder Equity = 2.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.02% (Net Income 255.0m / Total Assets 3.23b)
RoE = 9.90% (Net Income TTM 255.0m / Total Stockholder Equity 2.58b)
RoCE = 11.05% (EBIT 289.2m / Capital Employed (Equity 2.58b + L.T.Debt 38.9m))
RoIC = 9.48% (NOPAT 244.4m / Invested Capital 2.58b)
WACC = 8.82% (E(6.05b)/V(6.09b) * Re(8.88%) + D(38.9m)/V(6.09b) * Rd(0.29%) * (1-Tc(0.15)))
Discount Rate = 8.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.30%
[DCF Debug] Terminal Value 75.96% ; FCFF base≈377.1m ; Y1≈397.4m ; Y5≈467.3m
Fair Price DCF = 126.5 (EV 7.00b - Net Debt -663.0m = Equity 7.66b / Shares 60.6m; r=8.82% [WACC]; 5y FCF grow 5.89% → 2.90% )
EPS Correlation: -18.73 | EPS CAGR: -48.03% | SUE: -4.0 | # QB: 0
Revenue Correlation: 6.08 | Revenue CAGR: -3.55% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.36 | Chg30d=+0.050 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-09-30): EPS=4.26 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+0.5% | Growth Revenue=+4.8%
EPS next Year (2027-09-30): EPS=4.60 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+8.0% | Growth Revenue=+3.2%

Additional Sources for DLB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle